Latest Insider Transactions at Horizon Therapeutics Public LTD CO (HZNP)
This section provides a real-time view of insider transactions for Horizon Therapeutics Public LTD CO (HZNP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Horizon Therapeutics Public Ltd Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Horizon Therapeutics Public Ltd Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 23
2017
|
Paul W. Hoelscher EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,140
-10.86%
|
$100,540
$11.73 P/Share
|
|
Jun 23
2017
|
Paul W. Hoelscher EVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+19.21%
|
-
|
|
May 19
2017
|
Barry Moze EVP, Chief Admin. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,347
-10.5%
|
$73,470
$10.5 P/Share
|
|
May 19
2017
|
Barry Moze EVP, Chief Admin. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,075
+18.69%
|
-
|
|
May 10
2017
|
Michael G Grey Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+28.21%
|
$90,000
$9.48 P/Share
|
|
May 03
2017
|
William F Daniel Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
4,219
-14.75%
|
$63,285
$15.12 P/Share
|
|
May 03
2017
|
William F Daniel Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
13,953
+32.78%
|
-
|
|
May 03
2017
|
Michael G Grey Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
3,763
-19.59%
|
$56,445
$15.12 P/Share
|
|
May 03
2017
|
Michael G Grey Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
13,953
+42.07%
|
-
|
|
May 03
2017
|
Jeff Himawan Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
3,763
-26.97%
|
$56,445
$15.12 P/Share
|
|
May 03
2017
|
Jeff Himawan Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
13,953
+50.0%
|
-
|
|
May 03
2017
|
Ronald Pauli Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
3,763
-21.15%
|
$56,445
$15.12 P/Share
|
|
May 03
2017
|
Ronald Pauli Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
13,953
+43.95%
|
-
|
|
May 03
2017
|
Gino Santini Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
5,477
-30.78%
|
$82,155
$15.12 P/Share
|
|
May 03
2017
|
Gino Santini Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
13,953
+43.95%
|
-
|
|
May 03
2017
|
Virinder Nohria Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
13,953
+42.07%
|
-
|
|
May 03
2017
|
Thomas Watkins Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
13,953
+42.07%
|
-
|
|
Apr 01
2017
|
George P Hampton EVP, Primary Care Bus. Unit |
SELL
Payment of exercise price or tax liability
|
Direct |
2,937
-10.62%
|
$41,118
$14.78 P/Share
|
|
Apr 01
2017
|
George P Hampton EVP, Primary Care Bus. Unit |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+20.19%
|
-
|
|
Mar 23
2017
|
Brian K Beeler EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,955
-5.34%
|
$41,370
$14.56 P/Share
|
|
Mar 23
2017
|
Brian K Beeler EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
9,500
+14.65%
|
-
|
|
Mar 23
2017
|
Robert Carey EVP, Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,167
-29.3%
|
$198,338
$14.56 P/Share
|
|
Mar 23
2017
|
Robert Carey EVP, Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,000
+39.06%
|
-
|
|
Mar 23
2017
|
Paul W. Hoelscher EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,167
-18.43%
|
$198,338
$14.56 P/Share
|
|
Mar 23
2017
|
Paul W. Hoelscher EVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
31,000
+28.74%
|
-
|
|
Mar 23
2017
|
Vikram Karnani EVP & President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
2,955
-9.85%
|
$41,370
$14.56 P/Share
|
|
Mar 23
2017
|
Vikram Karnani EVP & President, International |
BUY
Exercise of conversion of derivative security
|
Direct |
9,500
+24.04%
|
-
|
|
Mar 23
2017
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,342
-12.83%
|
$60,788
$14.56 P/Share
|
|
Mar 23
2017
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,500
+21.92%
|
-
|
|
Mar 23
2017
|
Barry Moze EVP, Chief Admin. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,798
-14.04%
|
$123,172
$14.56 P/Share
|
|
Mar 23
2017
|
Barry Moze EVP, Chief Admin. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,250
+23.5%
|
-
|
|
Mar 23
2017
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,798
-4.37%
|
$123,172
$14.56 P/Share
|
|
Mar 23
2017
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,250
+8.73%
|
-
|
|
Mar 23
2017
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
57,125
-11.34%
|
$799,750
$14.56 P/Share
|
|
Mar 23
2017
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
125,000
+19.88%
|
-
|
|
Mar 05
2017
|
Robert Carey EVP, Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,268
-45.12%
|
$228,288
$16.11 P/Share
|
|
Mar 05
2017
|
Robert Carey EVP, Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,025
+49.52%
|
-
|
|
Mar 01
2017
|
Robert Carey EVP, Chief Business Officer |
SELL
Open market or private sale
|
Indirect |
30,000
-23.92%
|
$480,000
$16.0 P/Share
|
|
Feb 28
2017
|
Robert Carey EVP, Chief Business Officer |
SELL
Open market or private sale
|
Indirect |
1,808
-1.42%
|
$28,928
$16.48 P/Share
|
|
Feb 28
2017
|
Robert Carey EVP, Chief Business Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
6,913
+5.15%
|
$27,652
$4.31 P/Share
|
|
Jan 10
2017
|
Timothy J. Ackerman SVP, Commercial Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
9,675
+10.44%
|
$38,700
$4.94 P/Share
|
|
Jan 02
2017
|
Brian K Beeler EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,871
-7.79%
|
$61,936
$16.18 P/Share
|
|
Jan 02
2017
|
Brian K Beeler EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
11,200
+18.39%
|
-
|
|
Jan 02
2017
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,602
-6.48%
|
$201,632
$16.18 P/Share
|
|
Jan 02
2017
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,750
+12.09%
|
-
|
|
Jan 02
2017
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
37,703
-9.05%
|
$603,248
$16.18 P/Share
|
|
Jan 02
2017
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
81,675
+16.39%
|
-
|
|
Dec 16
2016
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,500
+4.82%
|
$17,000
$2.4 P/Share
|
|
Dec 01
2016
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,628
-9.74%
|
$49,932
$19.43 P/Share
|
|
Dec 01
2016
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,450
+23.86%
|
-
|